help button home button Biophys. J.
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH

Biophys. J. BioFAST: First Published June 10, 2005. doi:10.1529/biophysj.104.052837
© 2005 by the Biophysical Society.


A more recent version of this article appeared on September 1, 2005.
This Article
Right arrow Full Text (Rapid PDF)
Right arrow All Versions of this Article:
biophysj.104.052837v1
89/3/1681    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Buraei, Z.
Right arrow Articles by Elmslie, K. S
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Buraei, Z.
Right arrow Articles by Elmslie, K. S

CHANNELS, RECEPTORS, AND ELECTRICAL SIGNALING

Slowed N-type calcium channel (CaV2.2) deactivation by the cyclin-dependent kinase inhibitor Roscovitine

Zafir Buraei 1, Mircea Anghelescu 2 and Keith S Elmslie 1*

1 Tulane University Health Sciences Center
2 University of South Alabama

* To whom correspondence should be addressed. E-mail: kelmslie{at}tulane.edu.

Submitted on September 14, 2004
Revised on November 22, 2004
Accepted on 26 May 2005


   Abstract
The lack of a calcium channel agonist (e.g. BayK8644) for CaV2 channels has impeded their investigation. Roscovitine, a potent inhibitor of cyclin-dependent kinases (cdk) 1, 2 & 5, has recently been reported to slow the deactivation of P/Q-type calcium channels (CaV2.1). We show that roscovitine also slows deactivation (EC50 ~ 53 µM) of N-type calcium channels (CaV2.2) and investigate gating alterations induced by roscovitine. The onset of slowed deactivation was rapid (~ 2 sec), which contrasts with a slower effect of roscovitine to inhibit N-current (EC50 ~300 µM). Slow deactivation was specific to roscovitine since it could not be induced by a closely related cdk inhibitor, olomoucine (300 µM). Intracellularly applied roscovitine failed to slow deactivation, which implies an extracellular binding site. The roscovitine-induced slow deactivation was accompanied by a slight left shift in the activation vs. voltage relationship, slower activation at negative potentials, and increased inactivation. Additional data showed that roscovitine preferentially binds to the open channel to slow deactivation. A model where roscovitine reduced a backward rate constant between two open states was able to reproduce the effect of roscovitine on both activation and deactivation.

Key Words: Bullfrog sympathetic neurons, kinetic model, open-closed transitions, whole-cell patch clamp







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Copyright © 2005 by the Biophysical Society.